Free Float 79,35 %
Shares Float 215,02 M
Shares Outstanding 270,96 M
TOLERANZIA AB
Share · SE0007438577 · A143C1 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TOLERANZIA AB
No Price
Share Float & Liquidity
Company Profile for TOLERANZIA AB Share
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.
Company Data
Name TOLERANZIA AB
Company Toleranzia AB
Website
https://www.toleranzia.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
WKN A143C1
ISIN SE0007438577
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Charlotte Fribert
Market Capitalization 129 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Erik Dahlbergsgatan 11A, 411 26 Gothenburg
IPO Date 2015-12-16
Stock Splits
| Date | Split |
|---|---|
| 15.10.2020 | 243:200 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | TOL.ST |
| Frankfurt | 0EH.F |
More Shares
Investors who hold TOLERANZIA AB also have the following shares in their portfolio:
